Nuchido TIME+ Advanced NAD+ Supplement Review

No — and it's the most different product in this lineup, which is why we label it carefully. TIME+ contains no NMN and no NR. Instead it pairs nicotinamide (NAM, a cheap NAD+ precursor) with co-factors — R-alpha lipoic acid, rutin and apigenin — chosen to support the body's own NAD+ synthesis and recycling rather than flooding the system with a single precursor molecule. It's a whole-system NAD+ booster, not a precursor capsule. We include it as an honest alternative because it sidesteps the FDA's NMN exclusion entirely and takes a genuinely distinct approach. If you specifically want NMN, this isn't it.

Most products in this category supply a single NAD+ precursor — NMN or NR — and rely on your body to convert it. TIME+ instead targets the broader machinery: nicotinamide as the raw precursor, plus co-factors meant to support the enzymes that make and recycle NAD+. The theory is that boosting the body's own production and salvage pathways is more sustainable than dosing one molecule. It's a reasonable, differentiated rationale — and notably it's backed by a published human trial on the formula, which is rare here — but treat it as a distinct strategy with trial support, not a proven-superior one.

The brand states TIME+ was tested in a human clinical trial — genuine evidence on the formula itself — but the listing itself does not name an independent certifier seal such as NSF or USP, and no legible Supplement Facts photo is available in this listing, so we can't verify a testing or certification claim from the panel either way. That's an important distinction: a clinical trial demonstrates the product does something, while an NSF/USP seal verifies the contents of the bottle — and we can only confirm the trial claim here, not the bottle contents. For a named independent certification specifically, Elysium Basis (#6, NSF Certified for Sport) and Tru Niagen (#2, ISO/IEC-accredited testing) are the lineup's certified options. TIME+'s credibility rests on its trial and its longevity-scientist development.

At roughly $90 for a 90-capsule bottle that's a 30-day supply (3 capsules a day), TIME+ is the most premium-priced option in this lineup — about $3.00 per serving. You're paying for the multi-ingredient whole-system formula, the longevity-scientist development and the published clinical trial behind it, not for a low cost-per-gram. The proprietary blend also means you can't price it against a single ingredient the way you can a 500 mg NMN capsule. If cost is your priority, the budget NMN picks (Double Wood, #7) are a fraction of the price; TIME+ is the pick when the distinctive approach and trial backing are what you're after.

No — and we'd undercut our own credibility to imply otherwise. Like everything in this category, treat TIME+ as a promising experiment, not a longevity guarantee. Its published human trial is a real point in its favor and more than most picks here can show, but a trial demonstrating an effect on NAD+ or related markers is not the same as proof of extended lifespan or reversed aging — the hard-outcome human data simply doesn't exist for any NAD+ product. The whole-system approach is interesting and trial-backed; that's the honest reason to consider it, with realistic expectations.

1. [1] Martens 2018 PMID 29599478 — Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. A randomized, double-blind, placebo-controlled crossover trial showed chronic NAD+-precursor supplementation (NR, 1,000 mg/day) was well tolerated and effectively raised NAD+ metabolism in healthy middle-aged and older adults. Context for the NAD+-boosting premise behind TIME+, while noting TIME+ uses nicotinamide plus co-factors rather than NR or NMN.
2. [2] Elhassan 2019 PMID 31412242 — Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. A placebo-controlled crossover trial found 21 days of an NAD+ precursor raised the muscle NAD+ metabolome and produced anti-inflammatory signatures, but did NOT change mitochondrial bioenergetics or physical performance. The key caution applied to every NAD+ booster including TIME+: raising NAD+ biomarkers does not reliably translate into a functional or longevity benefit.
3. [3] Yoshino 2021 PMID 33888596 — Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. A randomized, placebo-controlled, double-blind trial found 10 weeks of oral NMN (250 mg/day) improved muscle insulin sensitivity in prediabetic women. The NMN reference point for this category — included to contextualize TIME+ as a non-NMN, nicotinamide-based alternative and keep the evidence framing honest across approaches.